Cytek Investor Presentation Deck

Investing to Capture the Cell Analysis Opportunity¹ Broad Customer Base and Global Presence Strong Financial Profile Validated Technology Platform 1. 1,997 Cytek Units Placed 1,450+ Cytek Peer-Reviewed Publications Nine months ended September 30, 2023 except as otherwise noted. 1,500+ Customers 70+ Countries $183.1M $9.3M TTM Revenue/ A-EBITDA $288M 9/30/23 Cash and Equivalents Luminex CE-IVDD Tonbo™ Cell Sorter Reagents Northern TM Lights ™M Cytek Aurora ™M 288 CYTEK TRANSCEND THE CONVENTIONAL 0 2023 2022 2021 2021 2020 2018 2017 4

View entire presentation